CDC vaccine advisory panel to study child immunization schedule, ... RSV vaccines are recommended for pregnant women between 32 and 36 weeks of pregnancy to pass on protection to a fetus, ...

GSK's 25,000-subject study is also due to read out in the spring of 2022 as the upcoming season starts to abate, while J&J's 23,000 trial – dubbed EVERGREEN – is pitching at a June 2023 ...

Study suggests vaccine adjuvant may help delay or prevent dementia onset. ... (RSV), a common virus that causes cold-like symptoms - was also linked to a significantly lower risk of developing ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot. The new ...